Anti-BTK Antibody, Rabbit Polyclonal (10578-T48)

Anti-BTK抗体, Rabbit Polyclonal

反应种属:Human
抗原名称:BTK
应用:WB, ELISA
标记:Unconjugated

用户验证的应用

经验证应用

项目详情
WB1:500-1:2000
ELISA1:5000-1:10000

推荐稀释说明

Optimal concentrations/dilutions should be determined by the end user.

详细信息

免疫原Recombinant Human BTK Protein (Catalog#10578-H08B)
宿主/亚型Polyclonal Rabbit IgG
抗体类型Polyclonal
产品类型Antibody
克隆号Polyclonal Rabbit IgG
产品形式Liquid
偶联物Unconjugated
纯化方式Protein A & Antigen Affinity
储存缓冲液0.2 μm filtered solution in PBS
储存条件This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

特异性

Human BTK

制备方法

Produced in rabbits immunized with purified, recombinant Human BTK (rh BTK; Catalog#10578-H08B; NP_000052.1; Met 1-Ser 659). BTK specific IgG was purified by Human BTK affinity chromatography.

运输条件

This antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.

背景信息

Bruton's tyrosine kinase (or BTK) is a type of kinase protein expressed in B lymphocytes and T cells. BTK contains a PH domain which binds phosphatidylinositol(3,4,5)-trisphosphate (PIP3). After binding to PIP3, BTK is induced to phosphorylate phospholipase C, which in turn hydrolyzes PIP2 into two second messagers, IP3 and DAG, which then modulate the activity of downstream proteins during B-cell signaling. Btk is also found implicated in the primary immunodeficiency disease X-linked agammaglobulinemia(Bruton's agammaglobulinemia). BTK played a key role in B-cell maturation as well as mast cell activation through the high-affinity IgE receptor. Patients with X-linked agammaglobulinemia have normal pre-B cell populations in their bone marrow but these B-cells can not mature and enter the circulation. Cancer Immunotherapy Immune Checkpoint Immunotherapy Targeted Therapy Full Name Bruton agammaglobulinemia tyrosine kinase Research Areas Cancer Drug Targets Related Pathways NF-kB (NFkB) Pathway B Cell Receptor Signaling Pathway References Hashimoto S, et al. (1996) Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood. 88(2): 561-73. Ohta Y, et al. (1994) Genomic organization and structure of Bruton agammaglobulinemia tyrosine kinase: localization of mutations associated with varied clinical presentations and course in X chromosome-linked agammaglobulinemia. PNAS. 91(19): 9062-6. Smith C, et al. (1994) Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. The Journal of Immunology. 152(2): 557-65.